Tumor-conditioned medium increases macromolecular permeability of endothelial cell monolayer.

The permeation of macromolecular FITC-labeled dextran (molecular weight 70,000) through bovine aortic endothelial cells (BAEC) monolayer, which were cultured for 5 days with conditioned medium prepared from mouse melanoma B16, was increased. However, when BAEC, which were cultured with normal medium until confluent, were treated with B16 conditioned medium (B16-CM) for 30 min, the permeability did not increase. The B16-CM also increased the permeability of the endothelial monolayers of bovine veins and the human umbilical vein, but did not increase that of the epithelial monolayer. The B16-CM did not alter the distribution or content of F-actin on the BAEC. BAEC cultured in the presence of B16-CM for 5 days were detached from the dish, and then seeded into a chamber at one-fifth of confluent cell density. After 5 days of culture in normal medium, the BAEC were grown to confluence and their permeability was increased. These findings suggest that B16-CM increased the endothelial permeability irreversibly without the decrease of F-actin, and that soluble factor(s) which were secreted from the tumor cells participate in the construction of the hyperpermeable structure of tumor vessels in vivo.

[1]  H. Maeda,et al.  Purification and identification of [hydroxyprolyl3]bradykinin in ascitic fluid from a patient with gastric cancer. , 1988, The Journal of biological chemistry.

[2]  H. Maeda,et al.  Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo. , 1992, Bioconjugate chemistry.

[3]  D. Rotrosen,et al.  Histamine type I receptor occupancy increases endothelial cytosolic calcium, reduces F-actin, and promotes albumin diffusion across cultured endothelial monolayers , 1986, The Journal of cell biology.

[4]  H. Dvorak,et al.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.

[5]  H. Movat,et al.  Increased permeability of microcarrier-cultured endothelial monolayers in response to histamine and thrombin. A model for the in vitro study of increased vasopermeability. , 1986, The American journal of pathology.

[6]  A. Malik,et al.  Phallacidin prevents thrombin-induced increases in endothelial permeability to albumin. , 1989, The American journal of physiology.

[7]  T. Mayumi,et al.  A comparison of drug transport through cultured monolayers of bovine brain capillary and bovine aortic endothelial cells. , 1994, Biological & pharmaceutical bulletin.

[8]  P. Phillips,et al.  Direct staining and visualization of endothelial monolayers cultured on synthetic polycarbonate filters. , 1988, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[9]  J. Cooper,et al.  Molecular sieving characteristics of the cultured endothelial monolayer , 1987, Journal of cellular physiology.

[10]  James M. Anderson,et al.  Characterization of ZO-1, a protein component of the tight junction from mouse liver and Madin-Darby canine kidney cells , 1988, The Journal of cell biology.

[11]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[12]  H. Dvorak,et al.  Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells. , 1991, The American journal of pathology.

[13]  P Delorme,et al.  An Easier, Reproducible, and Mass‐Production Method to Study the Blood–Brain Barrier In Vitro , 1990, Journal of neurochemistry.

[14]  M. Peach,et al.  Role of Endothelial Cell Cytoskeleton in Control of Endothelial Permeability , 1982, Circulation research.

[15]  B. Gumbiner,et al.  Identification of a 160-kDa polypeptide that binds to the tight junction protein ZO-1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Siliciano,et al.  Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia , 1986, The Journal of cell biology.

[17]  S. Nakagawa,et al.  Ascorbic acid stimulates barrier function of cultured endothelial cell monolayer , 1995, Journal of cellular physiology.

[18]  V. V. van Hinsbergh,et al.  Norepinephrine and iloprost improve barrier function of human endothelial cell monolayers: role of cAMP. , 1991, The American journal of physiology.

[19]  T. Takano,et al.  Transcellular transport of fluorescein dextran through an arterial endothelial cell monolayer. , 1986, Cell structure and function.

[20]  S. Nakagawa,et al.  Glial extracellular matrix modulates γ-glutamyl transpeptidase activity in cultured bovine brain capillary and bovine aortic endothelial cells , 1994, Brain Research.

[21]  E. M. Renkin Multiple pathways of capillary permeability. , 1977, Circulation research.

[22]  Bradbury Mw The structure and function of the blood-brain barrier. , 1984 .

[23]  R. Jain,et al.  Pore and fiber-matrix models for diffusive transport in normal and neoplastic tissues. , 1984, Microvascular research.

[24]  C. Song,et al.  Quantitative study of vascularity in Walker carcinoma 256. , 1971, Cancer research.

[25]  Benjamin Geiger,et al.  Cingulin, a new peripheral component of tight junctions , 1988, Nature.

[26]  H. Maeda,et al.  Enhanced Vascular Permeability in Solid Tumor Is Mediated by Nitric Oxide and Inhibited by Both New Nitric Oxide Scavenger and Nitric Oxide Synthase Inhibitor , 1994, Japanese journal of cancer research : Gann.

[27]  D. Connolly,et al.  Vascular permeability factor, an endothelial cell mitogen related to PDGF. , 1989, Science.

[28]  Tetsurou Yamamoto,et al.  Kinin‐generating Cascade in Advanced Cancer Patients and in vitro Study , 1991, Japanese journal of cancer research : Gann.

[29]  M. Mori,et al.  Monoclonal antibody 7H6 reacts with a novel tight junction-associated protein distinct from ZO-1, cingulin and ZO-2 , 1993, The Journal of cell biology.

[30]  X. Ding,et al.  SPARC (secreted protein acidic and rich in cysteine) regulates endothelial cell shape and barrier function. , 1994, Proceedings of the National Academy of Sciences of the United States of America.